Rezolute, Inc. (RZLT) Upgraded to Overweight at Cantor Fitzgerald

Market Context

Rezolute, Inc. operates in the Healthcare sector. The stock currently trades at $4.32 with a market capitalization of $129.4M.

Analyst upgrades often act as catalysts for near-term price movement, particularly when they come from major firms with significant institutional following. Cantor Fitzgerald's upgrade suggests their analysts see improving fundamentals, a more favorable risk-reward profile, or upcoming catalysts that could drive the stock higher.

Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.

Recent Analyst Activity for Rezolute, Inc.

Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.

Date	Firm	Rating	Price Target
Oct 06, 2026	Lake Street	Buy	N/A
Oct 06, 2026	Citizens	Market Outperform	N/A
Oct 06, 2026	Cantor Fitzgerald	Overweight	N/A
Sep 30, 2026	Lake Street	Buy	N/A
Sep 29, 2026	Craig-Hallum	Buy	N/A

Related Tools: Analyst Ratings Dashboard | View RZLT Stock Page